Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...
A recent study by Fred Hutch biochemist Christopher Lapointe, PhD, and his colleagues, uses innovative lab techniques to ...
Researchers at Fred Hutch Cancer Center are testing whether a collaborative AI research platform can accelerate the pace of ...
Soheil Meshinchi, MD, PhD, a world leader in developing novel approaches to treating acute myeloid leukemia (AML), has been ...
A new statistical analysis of patients with follicular lymphoma, made possible by 15 years of follow-up data from a SWOG and ...
Dietary supplements aren’t just biological interventions; they’re psychological interventions, said Fred Hutch psychologist ...
Fred Hutch Cancer Center scientists have developed an experimental strategy to give genetically engineered CAR T cells help they'd normally find within lymph nodes — but on the go, within the tumor.
Jana Batson was diagnosed with Hodgkin lymphoma after she insisted upon having a swollen lymph node examined. In addition to ...
SEATTLE – February 17, 2026 – Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein-Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is ...
March is the awareness month for colorectal cancer and multiple myeloma. If you’re interested in speaking to experts, contact media@fredhutch.org to schedule interviews. Scientists develop ...
The namesake award honors Dr. Harold “Hal” Weintraub, a molecular biologist who helped establish Fred Hutch’s Basic Sciences Division and died of brain cancer in 1995. Now in its 27th year, the award ...